Here, we aim to investigate the impact on COVID-19 of polymorphisms in ACE2 and TMPRSS2, serving as main SARS-CoV-2 cell entry gateways, as well as in Toll-like receptors (TLRs), acting as crucial actors of the immune system alert during infections. Here, ACE2 is linked to COVID-19.